ArticleBMC pregnancy and childbirth2026
Clinical impact of early-onset sepsis on outcomes of necrotizing enterocolitis: a retrospective case-control study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeEarly-onset sepsis (EOS) is a significant issue associated with high morbidity and mortality in newborns, yet it has not received adequate attention among neonatal necrotizing enterocolitis (NEC). This study aimed to investigate the clinical characteristics of NEC patients with EOS and to assess the association between EOS and NEC-related outcomes. PATIENTS AND
methodsThe retrospective case-control study included 196 NEC patients (Bell's stage ≥ II) admitted to a tertiary neonatal intensive care unit from January 2023 to March 2025. Of these, 98 patients with EOS were matched to 98 controls (without EOS) based on birth weight, gestational age, and gender. The medical records of eligible patients were reviewed, and the clinical characteristics were systematically analyzed. Statistical analyses were performed using R software.
resultsThe cohort included 196 patients, with a median gestational age of 32.1 weeks (IQR: 29.5, 34.4) and a median birth weight of 1615.0 g (IQR: 1227.5, 2050.0). Compared with the controls, cases showed significantly higher inflammatory markers (CRP and procalcitonin), lower platelet count, and higher incidences of hypoproteinemia, shock, and coagulopathy (all P < 0.05). Furthermore, ventilator support, blood transfusion, using of inotropes (dopamine), and Bell stage III were significantly more frequent among cases. Both the rate of surgical intervention [67.35% vs. 22.45%] and mortality [29.59% vs. 8.16%] were markedly elevated in the cases than in the controls. In multivariate conditional Logistic regression analysis, EOS emerged as an independent risk factor for both NEC-related surgical intervention [odds ratio (95% confidence interval) = 3.853 (1.724-8.612)] and death [odds ratio (95% confidence interval) = 5.017 (2.083-12.087)].
conclusionThe clinical characteristics of medical conditions identified in patients with EOS were distinct from those observed in patients without EOS. Moreover, EOS was associated with increased odds of NEC-related surgical intervention and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.